Goldman Sachs’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $59K | Sell |
|
|||||
|
2021
Q4 | $165K | Sell |
|
|||||
|
2021
Q3 | $176K | Sell |
|
|||||
|
2021
Q2 | $627K | Buy |
|
|||||
|
2021
Q1 | $583K | Buy |
|
|||||
|
2020
Q4 | $481K | Sell |
|
|||||
|
2020
Q3 | $522K | Buy |
|
|||||
|
2020
Q2 | $151K | Buy |
|
|||||
|
2020
Q1 | $89K | Sell |
|
|||||
|
2019
Q4 | $796K | Buy |
|
|||||
|
2019
Q3 | $228K | Buy |
|
|||||
|
2019
Q2 | $180K | Sell |
|
|||||
|
2019
Q1 | $283K | Sell |
|
|||||
|
2018
Q4 | $623K | Buy |
|
|||||
|
2018
Q3 | $1.16M | Buy |
|
|||||
|
2018
Q2 | $1.13M | Buy |
|
|||||
|
2018
Q1 | $281K | Sell |
|
|||||
|
2017
Q4 | $891K | Buy |
|
|||||
|
2017
Q3 | $783K | Buy |
|
|||||
|
2017
Q2 | $456K | Sell |
|
|||||
|
2017
Q1 | $731K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $329K | Buy |
|
|||||
|
2015
Q4 | $293K | Buy |
|
|||||
|
2015
Q3 | $191K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $294K | Buy |
|